Future Market Insights (FMI) delivers the key insights on the global infusion pumps market in its upcoming report titled “Infusion Pumps Market: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018 – 2028”. Volumetric pumps is the most lucrative segment in the global infusion pumps market and is projected to follow the same trend throughout the forecast period. The global infusion pumps market is expected to expand at a 5.4% CAGR over the forecast period.
Infusion Pumps Market: Dynamics
The global infusion pumps market is segmented based on product type, application and end users. The global infusion pumps market by product type is further segmented into syringe pumps, ambulatory pumps, volumetric pumps, implantable pumps, insulin pumps, enteral pumps, PCA pumps, and pump accessories. The volumetric pumps segment is further sub-segmented into peristaltic pumps and cassette/piston pumps. By application, the global infusion pump market is segmented into chemotherapy/oncology, paediatric/neonatology, analgesia, gastroenterology, haematology, and diabetes. The global infusion pumps market by end users is segmented into hospitals, ambulatory surgical centres, home care, clinics, and others. By region, the global infusion pumps market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Middle-East & Africa, China, and Japan.
The growth of the global infusion pumps market is driven by the increasing prevalence of different types of pains such as surgical pain (postoperative pain), cancer, and diabetes in the general population. Pain is one of the major reasons for hospital visits in over 50% of hospitalization cases globally. Furthermore, it has been estimated that 33% of cancer survivors suffer from chronic pain and need infusion therapy and direct administration of drugs for rapid relief. Diabetes cases have been increasing rapidly and as estimated by the NHS U.K., the number of diabetic cases has increased by ~60% over the past decade. These factors are expected to increase the demand for infusion therapy, and consequently infusion pumps.
Globally, the number of surgical procedures is increasing year by year, whereas prolonged waiting time for surgery in some of the developing countries is a major challenge. Pain management is essential, in which infusion pumps play an important role. Every year, more than 69 million surgeries are performed in the U.S., whereas globally more than 312.9 million surgeries were performed in 2012. Post-operative pain management is very essential in the first 24 hours after surgery, in which infusion pumps are generally required of adequate drug delivery.
The number of cancer cases is increasing and so is the prevalence of cancer pain, which is expected to drive the demand for infusion pumps over the forecast period. In the advanced stage, 80% cancer patients suffer from chronic pain that requires pain management along with chemotherapy, which thereby contributes to the growth of the global infusion pumps market.
The U.S. and most of the countries in Europe are witnessing a rapid increase in the geriatric population. According to the U.S. Department of Health and Human Services, people aged 65 years and above numbered 44.7 Mn in 2013 in the U.S., constituting 14.1% of the total population, which is expected to increase to 21.7% by 2040. Thus, the growing geriatric population is expected to drive the demand for infusion therapy and products in the near future.
Increased connectivity and wireless technology is expected to upsurge the demand for wearable ambulatory infusion pumps in the developed markets. These pumps are generally used for delivering pain management drugs. Wearable ambulatory infusion pumps are mostly preferred by the elderly population, who wish to receive treatment in home care settings.
Rapid advancements in technology is expected to encourage the companies operating in the market to launch user-friendly and technologically smart infusion systems. The companies are in the process of including detailed drug libraries in pumps, providing multi-directional interoperability and protecting data safety of the instrument and patients (better electronic health record management).
Infusion Pumps Market: Forecast
By product type, the volumetric pumps is expected to be the dominant segment in the global Infusion pumps market over the forecast period. In terms of revenue share, the volumetric pumps is expected to be the most lucrative segment in the global infusion pumps market. Whereas, the syringe pumps and ambulatory pumps largely contribute in growth of the global infusion pumps market. Infusion pump manufacturers are gradually incorporating advanced technologies, such as dose error reduction system (DERS) and barcode-enabled point-of-care (BPOC) systems, in the infusion pumps owing to development and better access to wireless technology. Smart pumps with DERS plus BPOC can prevent inappropriate drug delivery to the patients and ensure patient safety.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-859
Infusion Pumps Market: Competitive Landscape
Examples of some of the key participants covered in the report on the global infusion pumps market are B. Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc, Baxter International Inc, Smiths Medical, MOOG Inc, Johnson & Johnson Private Ltd, and ICU Medical, Inc.